Breast Cancer Stage I Clinical Trial
— MASTEROfficial title:
Minimal Invasive Microwave Ablation in Early Stage breaST cancER, a Feasibility Study
Verified date | May 2023 |
Source | University Medical Center Groningen |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In the Netherlands approximately one out of seven women will develop breast cancer during her life. Most of these breast cancers are early stage, 40% of the women have stage 1. Stage 1 breast cancer means that the cancer is small (size <2cm) and only in the breast tissue or it might be found in lymph nodes close to the breast. The standard treatment for stage 1 breast cancer is breast conserving surgery (BCS), sentinel lymph node procedure (SLNP) and additional radiotherapy. This standard treatment protocol results in a10 years survival rate of 95% for stage 1 disease. However, nowadays there is a discussion whether these early stage breast cancer could be treated less invasively. To reduce the invasiveness of breast cancer treatment, without compromising breast cancer specific survival, minimally invasive ablation procedure of the breast tumor can be an option for small breast lesions. Patients with a tumor size<2 cm will undergo ultra guided microwave ablation (MWA) with local anesthesia. After a small incision 2-3 millimeters, an MWA electrode is placed at the end of the tumor with ultrasound guidance. The microwaves in MWA create heat around the needle and destroy the cancer cells. There are several advantages of ablation procedures: it is a minimal invasive technique, with a small or absent cutaneous scar and thereby potentially improving patient quality of life. Furthermore, ablative treatment can be done under local anesthesia and/or conscious sedation instead of general anesthesia and in daycare setting, which can reduce treatment cost. A post procedural MRI (after ablation) can determine whether the ablation procedure of the tumor volume is complete. The purpose of this study is to assess whether minimally invasive microwave ablation (MWA) followed by postprocedural MRI scan can be an alternative treatment for breast surgery in early stage breast cancer. Is the quality of life, the cosmetic outcome, fear of breast cancer recurrence, and costs in patient treated with MWA comparable or better compared to patients treated with breast surgery?
Status | Not yet recruiting |
Enrollment | 15 |
Est. completion date | June 1, 2024 |
Est. primary completion date | June 1, 2024 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - age should be 18 years and older - a solid non-lobular invasive breast tumor with a size <2cm based upon ultrasound and MRI measurements - without mammographic or MRI evidence of extensive disease - no involved lymph nodes on ultrasound and MRI scan. Exclusion Criteria: - more than one breast tumor, - (lymph node) metastases - breast implants - indication for neoadjuvant chemotherapy. - pacemaker, - pregnant - breastfeeding |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University Medical Center Groningen |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | MWA followed by MRI in breast tumors | MWA will be succesfull if less than 20% of the patients has residual disease | 1 year | |
Secondary | Cosmetic outcome | Breast Q questionaire | Timepoints 4 days and 2 weeks after MWA and timepoints 4 days, 2 weeks and 2 months after surgery | |
Secondary | breast cancer recurrence fear | Lerman Breast Cancer Worry scal | Timepoints 4 days and 2 weeks after MWA and timepoints 4 days, 2 weeks and 2 months after surgery | |
Secondary | Quality of life | EuroQol 5D5L | Timepoints 4 days and 2 weeks after MWA and timepoints 4 days, 2 weeks and 2 months after surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05528263 -
Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)
|
N/A | |
Recruiting |
NCT06064812 -
A Phase I Clinical Trial of FWD1802 in Patients With ER+/HER2- BC.
|
Phase 1 | |
Terminated |
NCT04088435 -
Xoft® Intraoperative Radiotherapy (IORT) for Patients With Early-Stage Breast Cancer
|
||
Terminated |
NCT03723863 -
Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing Chemotherapy
|
N/A | |
Completed |
NCT00393341 -
Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer
|
N/A | |
Active, not recruiting |
NCT04180579 -
Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients
|
N/A | |
Recruiting |
NCT06275126 -
Optimizing Surgical Decisions in Young Adults With Breast Cancer
|
N/A | |
Not yet recruiting |
NCT05724758 -
Patient Reported Outcomes After Oncoplastic Breast Conserving Surgery
|
||
Active, not recruiting |
NCT03766009 -
Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making
|
N/A | |
Recruiting |
NCT05406531 -
The Effectiveness of Psychological Interventions in Psycho-neuroendocrine-immune Network in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT05861271 -
Adjuvant Pyrotinib and Capecitabine For HER2 Positive Micro Invasive Breast Cancer
|
Phase 2 | |
Recruiting |
NCT06006806 -
Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy
|
N/A | |
Recruiting |
NCT05898789 -
Virtual Rehabilitation for Cancer Survivors
|
N/A | |
Active, not recruiting |
NCT03927027 -
Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection
|
Phase 3 | |
Recruiting |
NCT05288777 -
Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06336538 -
Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT05219695 -
Medical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI)
|
N/A | |
Completed |
NCT02639208 -
Novel Social Media Intervention For Older Br CA Patients
|
N/A | |
Not yet recruiting |
NCT06268665 -
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
|
Phase 2 | |
Completed |
NCT02335671 -
Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy
|
N/A |